Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


McKesson (MCK) Is Up 8.9% After Raising Profit Forecast and Outlining Growth Priorities – Has the Bull Case Changed?

2025-09-27
McKesson announced a raised profit forecast and updated long-term growth targets during its 2025 Investor Day, highlighting an increased earnings outlook and a focus on high-margin businesses such as oncology and multispecialty services. The company also introduced organizational changes designed to accelerate growth and enhance transparency, underscoring management’s confidence in key segments like cancer medicines and biopharma as future drivers of performance. We'll review how McKesson’s...

Dividend Champion, Contender, And Challenger Highlights: Week Of September 28

2025-09-26
Read the latest dividend updates for Dividend Champions, Contenders, and Challengers. Track changes, ex-dividend, and pay dates.

JP Morgan Maintains McKesson (MCK) Overweight Recommendation

2025-09-26

Why McKesson (MCK) is a Top Momentum Stock for the Long-Term

2025-09-26
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today

2025-09-26
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

3 S&P 500 Stocks with Exciting Potential

2025-09-26
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding shareholders.

McKesson (MCK) Dips More Than Broader Market: What You Should Know

2025-09-25
McKesson (MCK) reached $736.52 at the closing of the latest trading day, reflecting a -3.16% change compared to its last close.

Clover Health, GoodRx, Cardinal Health, McKesson, and Humana Shares Plummet, What You Need To Know

2025-09-25
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.

Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock

2025-09-25
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

McKesson Stock Shoots To Record High. Health Products Giant Shows Improved Price Strength

2025-09-24
Health care products giant McKesson's stock broke out of a flat base Tuesday and jumped to a record high. Last quarter Irving, Texas-based McKesson reported a 5% earnings gain to $8.26 per share on a 23% surge in revenue to $97.8 billion. Meanwhile, the Relative Strength (RS) Rating for McKesson stock climbed into a higher percentile as it got a lift from 66 to 79 Wednesday.